Depression arises from a combination of genetic, biological, environmental, and lifestyle factors, and no single cause explains why one person develops it while another doesn’t. Roughly 332 million people worldwide live with depression, about 5.7% of all adults. Understanding the specific risk factors can help you recognize vulnerabilities in yourself or someone you care about.
Genetics and Family History
Depression runs in families. Twin studies estimate that genetics account for roughly 37% of the risk for major depressive disorder, while broader family-based studies put the figure between 28% and 44%. That means your genes create a significant predisposition, but they’re far from the whole story. Despite this strong hereditary signal, researchers have not been able to pinpoint specific gene variants responsible. The genetic contribution likely involves many genes with small individual effects, possibly combined with rare variants and gene-environment interactions that are difficult to isolate.
If a parent or sibling has had depression, your own risk is meaningfully higher. But heritability is not destiny. The remaining 56% to 72% of risk comes from environmental and personal factors, which is why identical twins don’t always share the condition.
Brain Chemistry and Structure
Three chemical messenger systems in the brain play central roles in depression. Serotonin is the most studied: when researchers experimentally lower serotonin production, people who are already vulnerable to depression (those with a family history or a past episode) tend to develop depressive symptoms. Reduced serotonin activity is linked to negative memory bias and disrupted processing of emotions.
Dopamine, the brain’s reward signal, also appears to be involved. People with depression consistently show reduced dopamine turnover, and lower dopamine activity in the brain’s reward center is associated with the inability to feel pleasure, one of depression’s hallmark symptoms. Norepinephrine, which helps regulate alertness and stress responses, shows signs of dysfunction in depressed individuals as well, though direct evidence is harder to gather.
Structural brain changes matter too. People with depression tend to have moderate volume reductions in the hippocampus, the prefrontal cortex, and the striatum. The hippocampal shrinkage appears to worsen with longer untreated episodes, which may increase stress sensitivity and raise the likelihood of future depressive episodes. This is one reason early treatment can be protective over the long term.
Adverse Childhood Experiences
What happens in childhood leaves a lasting imprint on mental health. Adverse childhood experiences, commonly called ACEs, include abuse, neglect, household dysfunction, and exposure to violence. Children exposed to four or more ACEs are roughly 2.2 times more likely to develop depression compared to those with fewer than four. This effect carries into adulthood: ACE exposure is consistently linked to higher rates of depression, anxiety, substance use problems, and suicidal behavior decades later.
The mechanism is partly biological. Chronic stress in early life can alter how the brain’s stress response system develops, making it more reactive and harder to regulate. That heightened stress sensitivity persists, lowering the threshold for depression when life challenges arise later.
Stressful Life Events
Major losses, relationship breakdowns, financial crises, and trauma all increase depression risk. The World Health Organization identifies abuse, severe losses, and other stressful events as key triggers. These don’t have to be dramatic: chronic daily stressors like caregiving burden, workplace conflict, or housing instability can accumulate and have a similar effect. The risk is highest when stressful events cluster together or when you lack a support network to buffer them.
Loneliness and Social Isolation
Few risk factors show as steep a relationship with depression as loneliness. People who report always feeling lonely have a predicted probability of depression around 50%, compared to just under 10% for those who never feel lonely. That’s a 40-percentage-point gap. The relationship follows a clear dose-response pattern: even occasional loneliness (“sometimes”) raises the predicted probability to about 31%.
Women experience a higher likelihood of depression than men at every level of loneliness. Among those who always feel lonely, women have a nearly 13-percentage-point higher risk than men. Importantly, loneliness is subjective. You can feel isolated in a crowd or deeply connected while living alone. It’s the perceived quality of social bonds, not just the number, that matters.
Sex and Hormonal Transitions
Depression is about 1.5 times more common in women than in men. Globally, 6.9% of adult women experience depression compared to 4.6% of men. Several hormonal transition points help explain this gap.
During puberty, the onset of fluctuating reproductive hormones coincides with a sharp rise in depression rates among girls. Pregnancy and the postpartum period are another high-risk window: more than 10% of pregnant women and new mothers experience depression. Perimenopause, the years of irregular cycles leading up to menopause, brings unpredictable swings in estrogen and progesterone, both of which help regulate serotonin and dopamine. These fluctuations can destabilize mood even in women with no prior history of depression. Premenstrual hormonal shifts also contribute to mood disruption for some women on a monthly basis.
Socioeconomic Status and Education
Lower socioeconomic status is consistently linked to higher depression rates across countries and cultures. A large meta-analysis found that people with low socioeconomic status have significantly higher odds of being depressed. Research across Finland, Poland, and Spain confirmed this pattern, with each unit increase in socioeconomic status reducing the odds of depression.
Education appears to be the strongest driver within this relationship. Lower educational attainment was associated with increased depression risk in every country studied, and the effect held up even after adjusting for other factors. Income mattered in some countries but not all. The protective effect of education likely works through multiple channels: better access to information about mental health, greater sense of control, expanded social networks, and more stable employment opportunities.
Chronic Medical Conditions
Living with a chronic illness substantially raises your risk of depression, and the relationship goes both ways. Conditions linked to higher depression rates include heart disease, diabetes, cancer, autoimmune diseases, epilepsy, HIV/AIDS, hypothyroidism, multiple sclerosis, and chronic pain. Neurological conditions like Parkinson’s disease and stroke can directly alter brain function in ways that trigger depressive symptoms, independent of the emotional burden of being ill.
The constant demands of managing a chronic condition (medications, appointments, physical limitations, uncertainty) create ongoing stress that wears down psychological resilience over time. Pain is a particularly potent driver: persistent pain changes how the brain processes emotions and rewards, creating fertile ground for depression to develop.
Alcohol and Substance Use
Alcohol use disorder and depression frequently co-occur, and each condition worsens the other. People with alcohol use disorder are 2.3 times more likely to have major depression than those without it. For people with alcohol dependence specifically, the risk jumps to 3.7 times higher. The relationship is bidirectional: heavy drinking disrupts brain chemistry in ways that promote depressive symptoms, while depression drives people toward alcohol as a coping mechanism.
This creates a cycle that’s difficult to break without addressing both conditions. Alcohol suppresses the brain’s reward and stress-regulation systems over time, and the withdrawal periods between drinking episodes can mimic or intensify depressive symptoms.
Certain Medications
Some commonly prescribed medications can trigger or worsen depressive symptoms. Corticosteroids, used for inflammation and autoimmune conditions, are among the most clearly linked. Certain anti-seizure medications that work on the brain’s calming pathways can cause fatigue, mental fog, and depressed mood. Some older blood pressure medications, particularly methyldopa, are associated with depressive symptoms and may pose greater risk for people with a history of prior depressive episodes.
The acne medication isotretinoin and the antimalarial mefloquine have also drawn concern. If you notice mood changes after starting a new medication, that’s worth raising with whoever prescribed it. The risk tends to be highest in people who already have other vulnerability factors for depression.